A highly efficient expression system for recombinant type II L-asparaginase from Escherichia coli (EC 3.5.1.1) was developed using a synthetic gene optimized for the folding energy of mRNA secondary structures in the 5-region. The engineered E. coli BL21DE3/pET28a-AsnSYN strain produced up to 291 ± 9 mg/L of enzymatically active protein (44.5 ± 2.6 mg/(L·OD)) in shake-flask cultures, 50% higher than the control strain with the native gene after 3 hours of induction. Codon optimization increased the mRNA secondary structure stability in the 5-region from –70 to –47 kcal/mol, potentially improving translation efficiency. The purified asparaginase met pharmacopeial standards, with a total yield ≥25%, specific activity 250 IU/mg, and high purity (no detectable impurities by electrophoresis,
Shaifutdinov et al. (Wed,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: